Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NeoGenomics Laboratories logo — Answers are in our DNA™

NeoGenomics Laboratories

Answers are in our DNA™

Founded 2002 United States Fort Myers, United States 1770 employees IPO Total: $750.90M Biotechnology, Health Care +1

General Information

Company Name NeoGenomics Laboratories
Founded Year 2002
Location United States Fort Myers, United States
Founders / Decision Makers
Team member Team member Team member Team member Team member
Employees 1770
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage IPO
Business Model B2B, B2C, B2D
Revenue Model Service Fee, Product Sales, Data Monetization
Social

BounceWatch is an independent company data service, not affiliated with NeoGenomics Laboratories. To contact NeoGenomics Laboratories, visit neogenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NeoGenomics Laboratories compare?

A PDF of NeoGenomics Laboratories and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NeoGenomics Laboratories soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NeoGenomics Laboratories

NeoGenomics Laboratories, founded in 2002, stands at the forefront of the Biotechnology, Health Care, and Pharmaceutical sectors. The company’s slogan, “One Lab. Vital Answers.,” encapsulates its mission of providing critical insights for personalized cancer treatment. Headquartered in the United States, NeoGenomics partners with physicians to enhance outcomes through tailored oncology solutions backed by an expert team.

The company’s dedication to precision oncology and its robust portfolio position it uniquely in the market. Its impressive track record includes a significant $200.00M Post IPO Equity investment round in May 2021, supported by high-profile investors such as Farallon Capital, Janus Henderson Investors, and RTW Investments. This financial backing underscores confidence in NeoGenomics' potential for growth and innovation within its industry.

Business keywords: Cancer Testing, Oncology Portfolio, Personalized Treatment, Partnership Programs, Pathologists, Oncologists, Cytogenetics, Flow Cytometry, Fluorescence In Situ Hybridization (FISH), Molecular Genetics, Immunohistochemistry, Pharma Research Services, Molecular Oncology, Pathology, Next-Gen Sequencing (NGS)

Services & Products

Oncology solutions and testing
Biopharma services
Regulatory support
Oncology lab services
Genomic and biomarker insights

Target Customers

Oncologists Biopharma companies Healthcare organizations Cancer patients

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity $200.00M 3
Farallon Capital Janus Henderson Investors RTW Investments
Farallon Capital, Janus Henderson Investors +1
01 May 2021
Post IPO Convertible $125.40M -
01 Apr 2020
Post-IPO Equity $150.00M -
01 May 2019
Post-IPO Equity $125.00M -
01 Aug 2018
Post-IPO Debt $150.00M -
01 Dec 2016
IPO Undisclosed -
01 Jan 2013
Seed $500.00K -
01 Mar 2009

NeoGenomics Laboratories Alternatives & Competitors

View All Alternatives
NeoGenomics Laboratories vs
Clarient
Clarient

Providing clarity in cancer diagnostics with community-focused care and insightful therapy guidance.

Venture round
1001-5000 employees
Biotechnology, Health Care
Compare NeoGenomics Laboratories vs Clarient
NeoGenomics Laboratories vs
Empire Genomics
Empire Genomics United States

The First Choice For Fluorescence In Situ Hybridization

Debt Financing
18 employees
Biotechnology, Health Care
Compare NeoGenomics Laboratories vs Empire Genomics
NeoGenomics Laboratories vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Also compare with: NeoGenomics Laboratories vs ACT Genomics ACT Genomics View all alternatives

FAQ About NeoGenomics Laboratories

Answers are in our DNA™
NeoGenomics Laboratories was founded in 2002.
NeoGenomics Laboratories is headquartered in Fort Myers, United States.
NeoGenomics Laboratories operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Cancer Testing, Oncology Portfolio, Personalized Treatment and Partnership Programs. Its customers include Oncologists, Biopharma companies and Healthcare organizations.
NeoGenomics Laboratories has a B2B, B2C and B2D business model. Its revenue comes from Service Fee, Product Sales and Data Monetization.
NeoGenomics Laboratories has approximately 1770 employees.
NeoGenomics Laboratories has completed 7 funding rounds, raising a total of $750.90M. The latest funding stage is IPO.
NeoGenomics Laboratories offers: Oncology solutions and testing, Biopharma services, Regulatory support, Oncology lab services, Genomic and biomarker insights.
Top alternatives and competitors to NeoGenomics Laboratories include Clarient, Empire Genomics, OncoDNA, ACT Genomics, Agendia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeoGenomics Laboratories and Clarient are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NeoGenomics Laboratories, https://bouncewatch.com/company/neogenomics-laboratories, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes